Association of elevated serum soluble CD226 levels with the disease activity and flares of systemic lupus erythematosus

Abstract CD226 is an activating receptor expressed on the cell surface of natural killer cells and T cells. Although CD226 polymorphism is known to be involved in systemic lupus erythematosus (SLE), the involvement of soluble CD226 (sCD226) in SLE is still unknown. In the present study, we measured...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Miki Nakano, Masahiro Ayano, Kazuo Kushimoto, Shotaro Kawano, Kazuhiko Higashioka, Shoichiro Inokuchi, Hiroki Mitoma, Yasutaka Kimoto, Mitsuteru Akahoshi, Nobuyuki Ono, Yojiro Arinobu, Koichi Akashi, Takahiko Horiuchi, Hiroaki Niiro
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/184c7d5b436a488e8be4ca2c72aa394a
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:184c7d5b436a488e8be4ca2c72aa394a
record_format dspace
spelling oai:doaj.org-article:184c7d5b436a488e8be4ca2c72aa394a2021-12-02T15:08:39ZAssociation of elevated serum soluble CD226 levels with the disease activity and flares of systemic lupus erythematosus10.1038/s41598-021-95711-22045-2322https://doaj.org/article/184c7d5b436a488e8be4ca2c72aa394a2021-08-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-95711-2https://doaj.org/toc/2045-2322Abstract CD226 is an activating receptor expressed on the cell surface of natural killer cells and T cells. Although CD226 polymorphism is known to be involved in systemic lupus erythematosus (SLE), the involvement of soluble CD226 (sCD226) in SLE is still unknown. In the present study, we measured serum sCD226 levels using an enzyme-linked immunosorbent assay in 58 SLE patients and 33 healthy controls (HCs) and evaluated their associations with SLE Disease Activity Index 2000 (SLEDAI-2K), clinical manifestations, laboratory data, and the cumulative probability of flare. Serum sCD226 levels showed no significant differences between SLE patients and HCs. However, sCD226 levels were significantly elevated in active SLE patients with a SLEDAI-2K score of ≥ 20 compared with HCs. In SLE patients, sCD226 levels were significantly correlated with SLEDAI-2K scores and anti-dsDNA antibody titers. Moreover, the cumulative probability of flare was markedly higher in patients with high sCD226 than in those with low sCD226. In patients with neuropsychiatric involvement, sCD226 levels were elevated and reflected neuropsychiatric disease activity. These findings indicate that serum sCD226 levels are associated with disease activity and flares of SLE. Thus, it may be a useful biomarker for SLE, and its monitoring allows for more precise SLE management.Miki NakanoMasahiro AyanoKazuo KushimotoShotaro KawanoKazuhiko HigashiokaShoichiro InokuchiHiroki MitomaYasutaka KimotoMitsuteru AkahoshiNobuyuki OnoYojiro ArinobuKoichi AkashiTakahiko HoriuchiHiroaki NiiroNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-8 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Miki Nakano
Masahiro Ayano
Kazuo Kushimoto
Shotaro Kawano
Kazuhiko Higashioka
Shoichiro Inokuchi
Hiroki Mitoma
Yasutaka Kimoto
Mitsuteru Akahoshi
Nobuyuki Ono
Yojiro Arinobu
Koichi Akashi
Takahiko Horiuchi
Hiroaki Niiro
Association of elevated serum soluble CD226 levels with the disease activity and flares of systemic lupus erythematosus
description Abstract CD226 is an activating receptor expressed on the cell surface of natural killer cells and T cells. Although CD226 polymorphism is known to be involved in systemic lupus erythematosus (SLE), the involvement of soluble CD226 (sCD226) in SLE is still unknown. In the present study, we measured serum sCD226 levels using an enzyme-linked immunosorbent assay in 58 SLE patients and 33 healthy controls (HCs) and evaluated their associations with SLE Disease Activity Index 2000 (SLEDAI-2K), clinical manifestations, laboratory data, and the cumulative probability of flare. Serum sCD226 levels showed no significant differences between SLE patients and HCs. However, sCD226 levels were significantly elevated in active SLE patients with a SLEDAI-2K score of ≥ 20 compared with HCs. In SLE patients, sCD226 levels were significantly correlated with SLEDAI-2K scores and anti-dsDNA antibody titers. Moreover, the cumulative probability of flare was markedly higher in patients with high sCD226 than in those with low sCD226. In patients with neuropsychiatric involvement, sCD226 levels were elevated and reflected neuropsychiatric disease activity. These findings indicate that serum sCD226 levels are associated with disease activity and flares of SLE. Thus, it may be a useful biomarker for SLE, and its monitoring allows for more precise SLE management.
format article
author Miki Nakano
Masahiro Ayano
Kazuo Kushimoto
Shotaro Kawano
Kazuhiko Higashioka
Shoichiro Inokuchi
Hiroki Mitoma
Yasutaka Kimoto
Mitsuteru Akahoshi
Nobuyuki Ono
Yojiro Arinobu
Koichi Akashi
Takahiko Horiuchi
Hiroaki Niiro
author_facet Miki Nakano
Masahiro Ayano
Kazuo Kushimoto
Shotaro Kawano
Kazuhiko Higashioka
Shoichiro Inokuchi
Hiroki Mitoma
Yasutaka Kimoto
Mitsuteru Akahoshi
Nobuyuki Ono
Yojiro Arinobu
Koichi Akashi
Takahiko Horiuchi
Hiroaki Niiro
author_sort Miki Nakano
title Association of elevated serum soluble CD226 levels with the disease activity and flares of systemic lupus erythematosus
title_short Association of elevated serum soluble CD226 levels with the disease activity and flares of systemic lupus erythematosus
title_full Association of elevated serum soluble CD226 levels with the disease activity and flares of systemic lupus erythematosus
title_fullStr Association of elevated serum soluble CD226 levels with the disease activity and flares of systemic lupus erythematosus
title_full_unstemmed Association of elevated serum soluble CD226 levels with the disease activity and flares of systemic lupus erythematosus
title_sort association of elevated serum soluble cd226 levels with the disease activity and flares of systemic lupus erythematosus
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/184c7d5b436a488e8be4ca2c72aa394a
work_keys_str_mv AT mikinakano associationofelevatedserumsolublecd226levelswiththediseaseactivityandflaresofsystemiclupuserythematosus
AT masahiroayano associationofelevatedserumsolublecd226levelswiththediseaseactivityandflaresofsystemiclupuserythematosus
AT kazuokushimoto associationofelevatedserumsolublecd226levelswiththediseaseactivityandflaresofsystemiclupuserythematosus
AT shotarokawano associationofelevatedserumsolublecd226levelswiththediseaseactivityandflaresofsystemiclupuserythematosus
AT kazuhikohigashioka associationofelevatedserumsolublecd226levelswiththediseaseactivityandflaresofsystemiclupuserythematosus
AT shoichiroinokuchi associationofelevatedserumsolublecd226levelswiththediseaseactivityandflaresofsystemiclupuserythematosus
AT hirokimitoma associationofelevatedserumsolublecd226levelswiththediseaseactivityandflaresofsystemiclupuserythematosus
AT yasutakakimoto associationofelevatedserumsolublecd226levelswiththediseaseactivityandflaresofsystemiclupuserythematosus
AT mitsuteruakahoshi associationofelevatedserumsolublecd226levelswiththediseaseactivityandflaresofsystemiclupuserythematosus
AT nobuyukiono associationofelevatedserumsolublecd226levelswiththediseaseactivityandflaresofsystemiclupuserythematosus
AT yojiroarinobu associationofelevatedserumsolublecd226levelswiththediseaseactivityandflaresofsystemiclupuserythematosus
AT koichiakashi associationofelevatedserumsolublecd226levelswiththediseaseactivityandflaresofsystemiclupuserythematosus
AT takahikohoriuchi associationofelevatedserumsolublecd226levelswiththediseaseactivityandflaresofsystemiclupuserythematosus
AT hiroakiniiro associationofelevatedserumsolublecd226levelswiththediseaseactivityandflaresofsystemiclupuserythematosus
_version_ 1718388044768215040